Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$327K Buy
112,135
+3,851
+4% +$11.5K 0.08% 208
2026
Q2
$340K Buy
108,284
+11,600
+12% +$36.3K 0.09% 207
2026
Q1
$282K Buy
96,684
+16,567
+21% +$47.3K 0.09% 222
2025
Q4
$198K Buy
+80,117
New +$191K 0.06% 237

Other funds holding ABEV

Focused Alpha's ABEV Position: Q3 2026 in Review

Focused Alpha increased its Ambev (ABEV) stake by 3.6% in Q3 2026, buying an estimated $11.5K and bringing the position to 112,135 shares worth $327K. The position accounts for 0.08% of the portfolio, ranked #208.

Focused Alpha first reported a position in ABEV in Q4 2025 and has held it in 4 quarters since. The position peaked at $340K in Q2 2026. 329 funds tracked by Wall St. Rank hold ABEV as of Q3 2026.

  • Focused Alpha held 112,135 shares of Ambev worth $327K as of Q3 2026.
  • Focused Alpha bought 3,851 Ambev shares in Q3 2026, an estimated $11.5K.
  • Ambev made up 0.08% of Focused Alpha's portfolio in Q3 2026, its #208 holding.
  • Focused Alpha first reported a position in Ambev in Q4 2025 and has held it in 4 quarters since.
  • Focused Alpha's Ambev position peaked at $340K in Q2 2026.
  • 329 funds tracked by Wall St. Rank held Ambev as of Q3 2026.

Based on Focused Alpha's 13F filing for Q3 2026, filed 20 Oct 2026.